Clinical Trial

Motus Nova Foot Device for Patients With Hemiplegia

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Individuals with hemiplegia commonly demonstrate gait deviations such as difficulties with heel strike at initial contact, foot drop in swing, asymmetrical limb loading, muscle activation, and balance impairments. This study evaluates whether a therapeutic device (Motus Nova Foot; FDA approved) used in the home setting can increase heel strike, decrease limp, improve foot clearance in swing phase, improve quality of active muscle contraction of the affected limb, and improve balance. The Motus Nova Foot moves the ankle/foot and uses guided computer/video activities to encourage active participation while automatically recording device use and duration.
Trial Details
NCT Number NCT07754773
Lead Sponsor MultiCare Health System Research Institute
Conditions Hemiplegia, Cerebral Palsy, Hemiplegic Cerebral Palsy
Enrollment 5 participants
Start Date 2026-09
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-10